Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 501–600 of 1,133
BMP signaling in vascular diseases
Cai, J., Pardali, E., Sánchez-Duffhues, G., & ten Dijke, P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.030 · Cited by 269
Female Human iPSCs Retain an Inactive X Chromosome
Tchieu, J., Kuoy, E., Chin, M. H., Trinh, H., Patterson, M., Sherman, S. P., Aimiuwu, O., Lindgren, A., Hakimian, S., Zack, J. A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.024 · Cited by 279
“iPSCs are obtained from differentiated mouse or human cells by forced expression of a few transcription factors related to pluripotency, most commonly consisting of Oct4, Sox2, c-Myc, and Klf4 (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundSommer, C. A., Sommer, A. G., Longmire, T. A., Christodoulou, C., Thomas, D. D., Gostissa, M., Alt, F. W., Murphy, G. J., Kotton, D. N., & Mostoslavsky, G. (2010) · Stem Cells · doi:10.1002/stem.255 · Cited by 269
The Stem Cell Niche in Regenerative Medicine
Wagers, A. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.018 · Cited by 269
“The groundbreaking development of induced reprogramming technology (Park et al., 2008a, 2008b; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007), and the resulting possibility of generating disease-specific induced pluripotent stem cells (iPSCs) from almost any human patient…”
BackgroundInduced pluripotent stem cells in medicine and biology
Takahashi, K., & Yamanaka, S. (2013) · Development · doi:10.1242/dev.092551 · Cited by 265
“Human iPSCs were first established from dermal fibroblasts (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundBioinspired mineralized collagen scaffolds for bone tissue engineering
Li, Z., Du, T., Ruan, C., & Niu, X. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.11.004 · Cited by 272
Self-renewal and differentiation capacity of young and aged stem cells
Roobrouck, V. D., Ulloa-Montoya, F., & Verfaillie, C. M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.006 · Cited by 268
A defined glycosaminoglycan-binding substratum for human pluripotent stem cells
Klim, J. R., Li, L., Wrighton, P. J., Piekarczyk, M. S., & Kiessling, L. L. (2010) · Nature Methods · doi:10.1038/nmeth.1532 · Cited by 271
“1532" language="eng" relation="no"> Human pluripotent stem cells have the remarkable capacity to both self-renew indefinitely and differentiate into many different cell type”
BackgroundCommon variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Diskin, S. J., Capasso, M., Schnepp, R. W., Cole, K. A., Attiyeh, E. F., Hou, C., Diamond, M., Carpenter, E. L., Winter, C., Lee, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2387 · Cited by 266
Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
Bradshaw, A., Wickremsekera, A., Tan, S. T., Peng, L., Davis, P. F., & Itinteang, T. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00021 · Cited by 258
“Deletion of NANOG from murine ESCs results in a loss of pluripotency (154) and NANOG has been used as a marker in the induction of pluripotent stem cell characteristics in normal human fibroblasts (112, 155).”
MethodCurrent status of pluripotent stem cells: moving the first therapies to the clinic
Kimbrel, E. A., & Lanza, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4738 · Cited by 261
Appelt-Menzel, A., Cubukova, A., Günther, K., Edenhofer, F., Piontek, J., Krause, G., Stüber, T., Walles, H., Neuhaus, W., & Metzger, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.021 · Cited by 274
“We demonstrated the pluripotency of hiPSCs as well as the multipotency of NSCs by expression of characteristic markers; this was in line with previous studies (Yu et al., 2007; Yan et al., 2013; Chen et al., 2015).”
ResultChiorazzi, N., & Ferrarini, M. (2011) · Blood · doi:10.1182/blood-2010-07-155663 · Cited by 264
Woll, P. S., Grzywacz, B., Tian, X., Marcus, R. K., Knorr, D. A., Verneris, M. R., & Kaufman, D. S. (2009) · Blood · doi:10.1182/blood-2008-06-165225 · Cited by 268
Induced pluripotent stem cells: opportunities and challenges
Okita, K., & Yamanaka, S. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0016 · Cited by 261
Stem and progenitor cell-mediated tumor selective gene therapy
Aboody, K. S., Najbauer, J., & Danks, M. K. (2008) · Gene Therapy · doi:10.1038/gt.2008.41 · Cited by 270
Cheung, A. Y. L., Horvath, L. M., Grafodatskaya, D., Pasceri, P., Weksberg, R., Hotta, A., Carrel, L., & Ellis, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr093 · Cited by 271
Forbester, J. L., Goulding, D., Vallier, L., Hannan, N., Hale, C., Pickard, D., Mukhopadhyay, S., & Dougan, G. (2015) · Infection and Immunity · doi:10.1128/iai.00161-15 · Cited by 270
“For example, it is possible to generate hIPSCs, and subsequently iHOs, from individuals with distinct genetic architectures or those harboring mutations in known human genes (36).”
BackgroundLIN28 Binds Messenger RNAs at GGAGA Motifs and Regulates Splicing Factor Abundance
Wilbert, M. L., Huelga, S. C., Kapeli, K., Stark, T. J., Liang, T. Y., Chen, S. X., Yan, B. Y., Nathanson, J. L., Hutt, K. R., Lovci, M. T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.004 · Cited by 267
“Consistent with this pattern of expression, LIN28 has been shown to be important in the maintenance of embryonic stem (ES) cell pluripotency and efficacy of induced pluripotent stem cell (iPSC) derivation (Newman and Hammond, 2010; Yu et al., 2007).”
BackgroundTissue engineering by decellularization and 3D bioprinting
Garreta, E., Oria, R., Tarantino, C., Pla-Roca, M., Prado, P., Fernández-Avilés, F., Campistol, J. M., Samitier, J., & Montserrat, N. (2017) · Materials Today · doi:10.1016/j.mattod.2016.12.005 · Cited by 263
Stepwise differentiation of pluripotent stem cells into retinal cells
Osakada, F., Ikeda, H., Sasai, Y., & Takahashi, M. (2009) · Nature Protocols · doi:10.1038/nprot.2009.51 · Cited by 269
“1a,c ), ES cells and induced pluripotent stem cell”
BackgroundRufaihah, A. J., Huang, N. F., Jamé, S., Lee, J. C., Nguyen, H. N., Byers, B., De, A., Okogbaa, J., Rollins, M., Reijo-Pera, R., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.230938 · Cited by 263
FOXO1 is an essential regulator of pluripotency in human embryonic stem cells
Zhang, X., Yalcin, S., Lee, D.-F., Yeh, T.-Y. J., Lee, S.-M., Su, J., Mungamuri, S. K., Rimmelé, P., Kennedy, M., Sellers, R., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2293 · Cited by 265
“Identification of key regulators of ESC pluripotency provided a foundation for somatic cell reprogrammin”
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells
Diekman, B. O., Christoforou, N., Willard, V. P., Sun, H., Sanchez-Adams, J., Leong, K. W., & Guilak, F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210422109 · Cited by 254
Li, M., He, Y., Dubois, W., Wu, X., Shi, J., & Huang, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.020 · Cited by 264
“In response to DNA damage, p53 represses many ES cell- or iPS cell-associated genes, such as Oct4, Sox2, Nanog, Sall4, Esrrb, Sall4, Utf1, Prdm14, n-Myc, and c-Myc.”
InfluentialScalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264
Kuo, T.-C., Chen, C.-T., Baron, D., Onder, T. T., Loewer, S., Almeida, S., Weismann, C. M., Xu, P., Houghton, J.-M., Gao, F.-B., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2332 · Cited by 258
“We first tested the role of MB d s during reprogrammin”
MethodDrug resistance: Still a daunting challenge to the successful treatment of AML
Shaffer, B. C., Gillet, J.-P., Patel, C., Baer, M. R., Bates, S. E., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.02.001 · Cited by 259
“Indeed, it was shown that either a loss of tumor suppressor function or a gain of oncogenic activity may cause the dedifferentiation of committed cells to cells possessing the stem cell property of self-renewal (Utikal et al., 2009; Yu et al., 2007).”
BackgroundMica, Y., Lee, G., Chambers, S. M., Tomishima, M. J., & Studer, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.025 · Cited by 257
“The derivation of PSCs from human fibroblasts (Park et al., 2008a; Takahashi et al., 2007; Yu et al., 2007) has been successfully applied to model human diseases (Dimos et al., 2008; Ebert et al., 2009; Park et al., 2008b), including disorders of the NC such as familial dysautonomia (Lee et al.,…”
MethodEfficient Feeder-Free Episomal Reprogramming with Small Molecules
Yu, J., Chau, K. F., Vodyanik, M. A., Jiang, J., & Jiang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017557 · Cited by 254
“These approaches could produce tumorigenic insertional mutations, and residual or reactivation of transgene expression during iPSC differentiation could affect lineage choice and the functionality of iPSC derivatives [2,9].”
BackgroundMethodSelf-citationPhenotypic correction of murine hemophilia A using an iPS cell-based therapy
Xu, D., Alipio, Z., Fink, L. M., Adcock, D. M., Yang, J., Ward, D. C., & Ma, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812090106 · Cited by 261
“Following the seminal work of Yamanaka and co-workers (9, 10), we and other laboratories (11) have been able to derive iPS cells successfully from fibroblasts of both mouse and human origin (data not shown).”
BackgroundMcIntosh, B. E., Brown, M. E., Duffin, B. M., Maufort, J. P., Vereide, D. T., Slukvin, I. I., & Thomson, J. A. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.12.005 · Cited by 255
“Pluripotent stem cell (PSC) technology offers one potential route to re-establish human thymic function in humanized mouse models (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundSelf-citationProteomic and phosphoproteomic comparison of human ES and iPS cells
Phanstiel, D. H., Brumbaugh, J., Wenger, C. D., Tian, S., Probasco, M. D., Bailey, D. J., Swaney, D. L., Tervo, M. A., Bolin, J. M., Ruotti, V., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1699 · Cited by 259
“Based on morphology, capacity to self-renew and developmental potential, iPSCs are nearly indistinguishable from their embryonic stem cell (ESC) counterpart”
Self-citationSystematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization
Roberts, B., Haupt, A., Tucker, A., Grancharova, T., Arakaki, J., Fuqua, M. A., Nelson, A., Hookway, C., Ludmann, S. A., Mueller, I. A., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-03-0209 · Cited by 262
Villa-Diaz, L. G., Ross, A. M., Lahann, J., & Krebsbach, P. H. (2013) · Stem Cells · doi:10.1002/stem.1260 · Cited by 253
Sebat, J., Levy, D. L., & McCarthy, S. E. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.10.004 · Cited by 260
Hu, K., Yu, J., Suknuntha, K., Tian, S., Montgomery, K., Choi, K.-D., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2011) · Blood · doi:10.1182/blood-2010-07-298331 · Cited by 254
Self-citationLapillonne, H., Kobari, L., Mazurier, C., Tropel, P., Giarratana, M.-C., Zanella-Cleon, I., Kiger, L., Wattenhofer-Donze, M., Puccio, H., Hebert, N., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023556 · Cited by 242
“Human fetal fibroblasts IMR-90 and an adult skin primary fibroblast cell line from a healthy donor were used to obtain hiPSC clones as previously described by Thomson’s group.(13) The fetal hiPSC IMR90-16 had a normal karyotype (Online Supplementary Figure S1A).”
InfluentialDirect lineage conversions: unnatural but useful?
Vierbuchen, T., & Wernig, M. (2011) · Nature Biotechnology · doi:10.1038/nbt.1946 · Cited by 259
Stem cells in retinal regeneration: past, present and future
Ramsden, C. M., Powner, M. B., Carr, A.-J. F., Smart, M. J. K., da Cruz, L., & Coffey, P. J. (2013) · Development · doi:10.1242/dev.092270 · Cited by 253
“Other groups have achieved similar results using different combinations of transcriptions factors, such as Oct4, Sox2, Nanog and Lin28, which avoids the use of Myc, a known proto-oncogene (Yu et al., 2007).”
ResultWarlich, E., Kuehle, J., Cantz, T., Brugman, M. H., Maetzig, T., Galla, M., Filipczyk, A. A., Halle, S., Klump, H., Schöler, H. R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.314 · Cited by 259
Margariti, A., Winkler, B., Karamariti, E., Zampetaki, A., Tsai, T.-N., Baban, D., Ragoussis, J., Huang, Y., Han, J.-D. J., Zeng, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205526109 · Cited by 258
“In comparison with embryonic stem cells, they could offer a tool for clinical application that does not raise either ethical or alloimmune concerns. iPS cell generation is mainly based on the sufficient delivery of a combination of key transcription factors, such as c-Myc, Klf4, Oct4, and Sox2 (2), or Lin28 and Nanog…”
BackgroundHuman germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells
Panula, S., Medrano, J. V., Kee, K., Bergström, R., Nguyen, H. N., Byers, B., Wilson, K. D., Wu, J. C., Simon, C., Hovatta, O., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq520 · Cited by 254
“, submitted for publication), and iPS(IMR90) with a normal 46:XX karyotype available from the National Stem Cell Bank, derived using fetal fibroblasts and OCT3/4, SOX2, NANOG and LIN28 reprogramming factors (2).”
MethodGenetic and epigenetic stability of human pluripotent stem cells
Lund, R. J., Närvä, E., & Lahesmaa, R. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3271 · Cited by 250
Induced pluripotent stem cells for neural tissue engineering
Wang, A., Tang, Z., Park, I.-H., Zhu, Y., Patel, S., Daley, G. Q., & Li, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.070 · Cited by 255
“, skin fibroblasts) can be reprogrammed into induced pluripotent stem cells (iPSCs) by the activation of a limited number of genes (transgenes) such as Oct3/4, Sox2, c-Myc and KLF4 [1,2] or Oct3/4, Sox2, Nanog and Lin28 [3].”
Ageing and neurodegenerative diseases
Hung, C.-W., Chen, Y.-C., Hsieh, W.-L., Chiou, S.-H., & Kao, C.-L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.006 · Cited by 247
“…stem (iPS) cells could be generated from mouse mbryonic fibroblasts as well as from adult human fibroblasts via he retrovirus-mediated transfection of four transcription factors; ct3/4, Sox2, c-Myc, and Klf-4 (Okita et al., 2007; Park et al., 2008; akahashi et al., 2007; Yu et al., 2007).”
BackgroundGeneration of Endoderm-Derived Human Induced Pluripotent Stem Cells From Primary Hepatocytes
Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y.-Y. (2010) · Hepatology · doi:10.1002/hep.23626 · Cited by 250
“Similar to human embryonic stem (hES) cells, human iPS cells have been shown to be pluripotent in in vitro differentiation and in vivo teratoma assays.(9-14) Disease-specific iPS cell lines have been generated from fibroblasts and blood cells, and some of the disease features have been recapitulated in tissue culture…”
BackgroundInfluentialGonzalez, F., Barragan Monasterio, M., Tiscornia, G., Montserrat Pulido, N., Vassena, R., Batlle Morera, L., Rodriguez Piza, I., & Belmonte, J. C. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901471106 · Cited by 249
“Moreover, reprogramming can be attained using different combinations of exogenous factors: human fibroblasts have been reprogrammed with Oct4, Sox2, Nanog, and Lin28 (14), and c-Myc is not strictly required for reprogramming, although it enhances its efficiency and speed (15, 16).”
BackgroundProgramming human pluripotent stem cells into white and brown adipocytes
Ahfeldt, T., Schinzel, R. T., Lee, Y.-K., Hendrickson, D., Kaplan, A., Lum, D. H., Camahort, R., Xia, F., Shay, J., Rhee, E. P., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2411 · Cited by 248
General Review on In Vitro Hepatocyte Models and Their Applications
Guguen-Guillouzo, C., & Guillouzo, A. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-688-7_1 · Cited by 239
The complexities of microRNA regulation: mirandering around the rules
Breving, K., & Esquela-Kerscher, A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.09.016 · Cited by 244
“lar de-differentiation (Ambros and Horvitz, 1984; Pasquinelli and Ruvkun, 2002; Yu et al., 2007).”
Good manufacturing practice and clinical-grade human embryonic stem cell lines
Unger, C., Skottman, H., Blomberg, P., Sirac Dilber, M., & Hovatta, O. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn079 · Cited by 247
“The new development of reprogramming somatic cells into highly potential hESCs (induced pluripotent stem cells), now also successful in humans, may in the future make this possible (48,49).”
BackgroundExtreme Makeover: Converting One Cell into Another
Zhou, Q., & Melton, D. A. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.015 · Cited by 246
“In one approach, this culminated in the discovery by Yamanaka and colleagues that adult skin cells can be induced to become pluripotent stem cells (iPSCs) in culture by a small set of transcription factors (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundJiang, H., Ren, Y., Yuen, E. Y., Zhong, P., Ghaedi, M., Hu, Z., Azabdaftari, G., Nakaso, K., Yan, Z., & Feng, J. (2012) · Nature Communications · doi:10.1038/ncomms1669 · Cited by 254
Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells
Qian, T., Maguire, S. E., Canfield, S. G., Bao, X., Olson, W. R., Shusta, E. V., & Palecek, S. P. (2017) · Science Advances · doi:10.1126/sciadv.1701679 · Cited by 254
Wahlin, K. J., Maruotti, J. A., Sripathi, S. R., Ball, J., Angueyra, J. M., Kim, C., Grebe, R., Li, W., Jones, B. W., & Zack, D. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00774-9 · Cited by 253
Emerging paradigms of regulated microRNA processing
Newman, M. A., & Hammond, S. M. (2010) · Genes & Development · doi:10.1101/gad.1919710 · Cited by 247
“Concordantly, Lin28 overexpression, in combination with several ES-specific transcription factors, is sufficient to reprogram somatic cells into induced pluripotent stem (iPS) cells (Yu et al. 2007).”
BackgroundHLA engineering of human pluripotent stem cells
Riolobos, L., Hirata, R. K., Turtle, C. J., Wang, P.-R., Gornalusse, G. G., Zavajlevski, M., Riddell, S. R., & Russell, D. W. (2013) · Molecular Therapy · doi:10.1038/mt.2013.59 · Cited by 253
Schwartz, S. D., Tan, G., Hosseini, H., & Nagiel, A. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-18681 · Cited by 245
Liu, X., Li, Q., Niu, X., Hu, B., Chen, S., Song, W., Ding, J., Zhang, C., & Wang, Y. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.16951 · Cited by 255
“Moreover, iPS-MSCs do not express pluripotency genes such as Nanog and Oct4, which are believed to be essential for the functional maintenance of iPSCs [40].”
BackgroundLim, R. G., Quan, C., Reyes-Ortiz, A. M., Lutz, S. E., Kedaigle, A. J., Gipson, T. A., Wu, J., Vatine, G. D., Stocksdale, J., Casale, M. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.021 · Cited by 253
“The development of iPSCs (Takahashi et al., 2007; Yu et al., 2007) and efficient protocols to generate BMECs (Lippmann et al., 2014) provide an opportunity to investigate the primary effects of neurodegenerative disease mutations on BMECs and their contribution to disease pathogenesis.”
Peng, S., Maihle, N. J., & Huang, Y. (2010) · Oncogene · doi:10.1038/onc.2009.500 · Cited by 250
Wang, W., Yang, J., Liu, H., Lu, D., Chen, X., Zenonos, Z., Campos, L. S., Rad, R., Guo, G., Zhang, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100893108 · Cited by 243
“We did not further characterize the FGF colonies because expressing 4F could also produce them (4, 6).”
BackgroundJeter, C. R., Yang, T., Wang, J., Chao, H.-P., & Tang, D. G. (2015) · Stem Cells · doi:10.1002/stem.2007 · Cited by 242
Cell therapy for the treatment of coronary heart disease: a critical appraisal
Wollert, K. C., & Drexler, H. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.1 · Cited by 251
“These cells can be reprogrammed to a pluripotent state by retroviral transduction of so-called 'stemness' transcription factors”
BackgroundCanfield, S. G., Stebbins, M. J., Morales, B. S., Asai, S. W., Vatine, G. D., Svendsen, C. N., Palecek, S. P., & Shusta, E. V. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13923 · Cited by 250
Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency
Hansson, J., Rafiee, M. R., Reiland, S., Polo, J. M., Gehring, J., Okawa, S., Huber, W., Hochedlinger, K., & Krijgsveld, J. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.014 · Cited by 229
“Introduction Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) by the forced expression of only four transcription factors (TFs): Oct4, Klf4, Sox2 and c-Myc (OKSM) (Park et al., 2008; Takahashi and Yamanaka, 2006; Yu et al., 2007). iPCS share many #Corresponding author.”
BackgroundResultInfluentialInduced Pluripotent Stem Cell Lines Derived from Equine Fibroblasts
Nagy, K., Sung, H.-K., Zhang, P., Laflamme, S., Vincent, P., Agha-Mohammadi, S., Woltjen, K., Monetti, C., Michael, I. P., Smith, L. C., et al. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9239-5 · Cited by 249
“When the first successful derivation attempts of iPS cells were reported in the mouse [8, 9] and later in the human [10, 11], huge hopes arose for using these as superior alternatives for ES cells in future cell-based therapies.”
BackgroundYakubov, E., Rechavi, G., Rozenblatt, S., & Givol, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.150 · Cited by 239
Stem cell therapies for spinal cord injury
Sahni, V., & Kessler, J. A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.73 · Cited by 243
Yu, P., Pan, G., Yu, J., & Thomson, J. A. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.001 · Cited by 243
“Human NANOG is part of a core transcriptional regulatory network in ESCs (Boyer et al., 2005) and is capable of enhancing the frequency of molecular reprogramming of human somatic cells into pluripotent cells (Yu et al., 2007).”
Self-citationClinical utility of stem cells for periodontal regeneration
Hynes, K., Menicanin, D., Gronthos, S., & Bartold, P. M. (2012) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00443.x · Cited by 239
“Following publication of Takahashi & Yamanaka s work, the first human-induced pluripotent stem cells were generated in 2007 by two groups using different sets of transcription factors (152, 177).”
InfluentialMinami, I., Yamada, K., Otsuji, T. G., Yamamoto, T., Shen, Y., Otsuka, S., Kadota, S., Morone, N., Barve, M., Asai, Y., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.015 · Cited by 248
“Culture of hESC, hiPSC, and Monkey ESC All PSC lines were maintained as described (Suemori and Nakatsuji, 2006). hESC lines used were KhES-1, KhES-3, H1, and H9 (Suemori et al., 2006; Thomson et al., 1998). hiPSC lines used were 253G1, IMR90-1, IMR90-4 (Takahashi et al., 2007; Yu et al., 2007), and RCHIPC0003.”
MethodInfluentialThe cancer stem cell hypothesis: in search of definitions, markers, and relevance
Shipitsin, M., & Polyak, K. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.14 · Cited by 231
“ipotent embryonic stem cell just by expressing the right combination of transcription factors in them.(26) Thus, the question is what would prevent a ‘differentiated’ cancer cell from acquiring similar changes and become a cancer stem cell? Another inconsistency related to the cancer stem cell model is its explanation…”
BackgroundCao, N., Liu, Z., Chen, Z., Wang, J., Chen, T., Zhao, X., Ma, Y., Qin, L., Kang, J., Wei, B., et al. (2012) · Cell Research · doi:10.1038/cr.2011.195 · Cited by 241
Stonesifer, C., Corey, S., Ghanekar, S., Diamandis, Z., Acosta, S. A., & Borlongan, C. V. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.004 · Cited by 241
“These cells can be transgene and vector free and are generated primarily from human fibroblasts via the induction of a suite of transcription factors, including Oct4, Sox2, Nanog, Klf4, cMyc and Lin-28 (Yu et al., 2007; Zhao et al., 2008; Mohamad et al., 2013; Wang et al., 2016a,b,c,d).”
Age‐Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
Hernández-Zimbrón, L. F., Zamora-Alvarado, R., Ochoa-De la Paz, L., Velez-Montoya, R., Zenteno, E., Gulias-Cañizo, R., Quiroz-Mercado, H., & Gonzalez-Salinas, R. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8374647 · Cited by 240
“recently described the iPSCs, which consist of a line of cells reprogrammed by the use of Thomson factors or Yamanaka factors, showing morphological characteristics and differentiation abilities similar to those of the hESCs [130, 131].”
BackgroundInhibition of pluripotent stem cell-derived teratoma formation by small molecules
Lee, M.-O., Moon, S. H., Jeong, H.-C., Yi, J.-Y., Lee, T.-H., Shim, S. H., Rhee, Y.-H., Lee, S.-H., Oh, S.-J., Lee, M.-Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303669110 · Cited by 246
“(2007) Structure-activity relationship study of [1,2,3]thiadiazole”
Dravet syndrome patient‐derived neurons suggest a novel epilepsy mechanism
Liu, Y., Lopez‐Santiago, L. F., Yuan, Y., Jones, J. M., Zhang, H., O'Malley, H. A., Patino, G. A., O'Brien, J. E., Rusconi, R., Gupta, A., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23897 · Cited by 243
H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
Peng, F., Li, T.-T., Wang, K.-L., Xiao, G.-Q., Wang, J.-H., Zhao, H.-D., Kang, Z.-J., Fan, W.-J., Zhu, L.-L., Li, M., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.438 · Cited by 244
“24,25 Accumulating evidence has indicated that LIN28 is overexpressed in advanced human malignancies and has a key role in the maintenance of CSCs. 26,27 LIN28A binds to conserved terminal loop of pre-let-7 elements and induce terminal uridylation (addition of uridine nucleotides) of pre-let-7 via…”
RNA structure maps across mammalian cellular compartments
Sun, L., Fazal, F. M., Li, P., Broughton, J. P., Lee, B., Tang, L., Huang, W., Kool, E. T., Chang, H. Y., & Zhang, Q. C. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0200-7 · Cited by 241
Kidder, B. L., Palmer, S., & Knott, J. G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0710 · Cited by 242
Predicting cell-type–specific gene expression from regions of open chromatin
Natarajan, A., Yardımcı, G. G., Sheffield, N. C., Crawford, G. E., & Ohler, U. (2012) · Genome Research · doi:10.1101/gr.135129.111 · Cited by 253
“A good example of the primacy of TFs in orchestrating programs of gene expression is demonstrated by the ability of ectopically expressed TFs to reprogram fibroblasts into induced pluripotent stem cells (Takahashi and Yamanaka 2006; Yu et al. 2007).”
BackgroundMason, M. J., Fan, G., Plath, K., Zhou, Q., & Horvath, S. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-327 · Cited by 243
“Figure 9 shows genes with relatively high that lack binding by the TFs Nanog, Oct4, Sox2, and Klf4 [10,11] and have low binding (≤ 2) by other TFs that maintain pluripotency (Smad1, Stat3, cMyc, nMyc, Esrrb, Tcfcp2l1, Zfx, and E2f1).”
BackgroundInfluentialMolecular genetics of tooth development
Bei, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.09.002 · Cited by 234
“In another study, iPS cells were generated from human fibroblasts using Oct4, Sox2, Nanog and Lin28 [40].”
MethodPluripotent Stem Cells: Current Understanding and Future Directions
Romito, A., & Cobellis, G. (2016) · Stem Cells International · doi:10.1155/2016/9451492 · Cited by 215
“…hESC-specific surface antigens, including stage-specific embryonic antigen-(SSEA-) 3 and 4, tumour-related antigens (TRA-1-60, TRA-1-81), pluripotency-associated TFs, high telomerase activity, and the ability to differentiate into cells of the three germ layers by teratoma formation [7, 119–121].”
Differential L1 regulation in pluripotent stem cells of humans and apes
Marchetto, M. C. N., Narvaiza, I., Denli, A. M., Benner, C., Lazzarini, T. A., Nathanson, J. L., Paquola, A. C. M., Desai, K. N., Herai, R. H., Weitzman, M. D., et al. (2013) · Nature · doi:10.1038/nature12686 · Cited by 237
Tanaka, A., Woltjen, K., Miyake, K., Hotta, A., Ikeya, M., Yamamoto, T., Nishino, T., Shoji, E., Sehara-Fujisawa, A., Manabe, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061540 · Cited by 236
“The establishment of human induced pluripotent stem cells (hiPSCs) [1,2] has paved the way for the generation of patientspecific stem cell resources.”
BackgroundRhee, Y.-H., Ko, J.-Y., Chang, M.-Y., Yi, S.-H., Kim, D., Kim, C.-H., Shim, J.-W., Jo, A.-Y., Kim, B.-W., Lee, H., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45794 · Cited by 236
Zou, J., Sweeney, C. L., Chou, B.-K., Choi, U., Pan, J., Wang, H., Dowey, S. N., Cheng, L., & Malech, H. L. (2011) · Blood · doi:10.1182/blood-2010-12-328161 · Cited by 236
Schenke-Layland, K., Rhodes, K. E., Angelis, E., Butylkova, Y., Heydarkhan-Hagvall, S., Gekas, C., Zhang, R., Goldhaber, J. I., Mikkola, H. K., Plath, K., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0033 · Cited by 239
“More recently, investigators have created iPS cells from adult human cells using either a combination of Oct4, Sox2, c-Myc, and Klf4, similar to the mouse system [7, 8], or Oct4, Sox2, Nanog homeobox (Nanog), and lin-28 homolog (LIN28) [ 9 ].”
BackgroundCho, H.-J., Lee, C.-S., Kwon, Y.-W., Paek, J. S., Lee, S.-H., Hur, J., Lee, E. J., Roh, T.-Y., Chu, I.-S., Leem, S.-H., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269589 · Cited by 239
MicroRNA Profiling of Human-Induced Pluripotent Stem Cells
Wilson, K. D., Venkatasubrahmanyam, S., Jia, F., Sun, N., Butte, A. J., & Wu, J. C. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0247 · Cited by 234
“…which were originally derived from IMR90 fetal fi broblasts (ATCC, Manassas, VA) using the reprogramming factors OCT4, SOX2, NANOG, and LIN28 [10]. hESCs (H7 from Wicell, Madison, WI) and iPSCs were maintained in the undifferentiated state using mTeSR™1 medium (StemCell Technologies,…”
Bone tissue engineering: state of the union
Shrivats, A. R., McDermott, M. C., & Hollinger, J. O. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.04.010 · Cited by 232
“15 Yu, J. et al. (2007) Induced pluripotent stem cell lines derived from human somatic”
Constitutive secretion of tau protein by an unconventional mechanism
Chai, X., Dage, J. L., & Citron, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.021 · Cited by 224
A review of cellularization strategies for tissue engineering of whole organs
Scarrit, M. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00043 · Cited by 234
“Induced pluripotent stem cells Another promising cell type for organ recellularization is induced pluripotent stem cells (iPSCs). iPSCs are generated by reprograming somatic cells using specific pluripotent genes that render an “embryonic-like” state (Yu et al., 2007).”
The emerging functions of histone demethylases
Agger, K., Christensen, J., Cloos, P. A., & Helin, K. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.003 · Cited by 231
Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 229
Mitochondrial Rejuvenation After Induced Pluripotency
Suhr, S. T., Chang, E. A., Tjong, J., Alcasid, N., Perkins, G. A., Goissis, M. D., Ellisman, M. H., Perez, G. I., & Cibelli, J. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014095 · Cited by 226
“The fibroblast cell lines — FIBA and FIBB — used in these analyses have been described previously[7], and were selected because at all stages of differentiation they appeared very similar to other cell lines used for analysis of pluripotency[3,4].”
ResultInduced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
Ebert, A. D., Liang, P., & Wu, J. C. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318247f642 · Cited by 222
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.